Chris Aholt

Critic
DISC Type : C

Co-founder and Managing Partner at Pineway Capital

New York, New York, United States

Overview

Chris Aholt is the Co-founder and Managing Partner of Pineway Capital, an investment firm focused on acquiring and growing a single great business. His background uniquely blends engineering, sales, and finance, with experience at J. P. Morgan, Stryker, and Smith & Nephew. He holds an MBA from MIT Sloan and a Bachelors from Stanford.

His academic pursuits highlight a deep interest in advanced technology. As an undergraduate researcher at Stanford, he worked in both the Artificial Intelligence Lab and the Brains in Silicon Lab, focusing on the intersection of engineering and complex biological systems. This demonstrates a foundational curiosity for cutting-edge innovation.

Unique fact: Chris co-authored a publication on "Haptic fMRI, " a novel platform combining functional neuroimaging with haptic virtual simulation to study motor control.

Personality Overview

Critic

Information Seeker

Objective Thinker

Unless the value is proven by data, they are unlikely to value fancy features.  It is very likely that they will negotiate pricing or other important terms. They like to take decisions independently and do not seek others' support often.

Topics They Care About

Business Acquisition
As Co-founder of Pineway Capital, his primary goal is to identify, acquire, and operate a business for long-term growth.
Healthcare Investing
His career progression from medical device R&D and sales to healthcare investment banking at J. P. Morgan shows a long-standing focus on this sector.
Medical Technology
Started his career as an R&D engineer for advanced surgical devices and later worked in orthopedic trauma sales, giving him deep industry insight.

Media Appearances

Our Team - Pineway Capital. Featured in Pineway Capital (official website)

See Now

Close friends from MIT launch Pineway Capital - Search Funds News. Featured in Search Funds News

See Now

Work History

9-2024
Co-founder and Managing Partner at Pineway Capital
6-2021 - 6-2024
Healthcare Investment Banking at J.P. Morgan
1-2016 - 6-2019
Orthopedic Trauma Sales Representative at Stryker
6-2014 - 1-2016
R&D Engineer - Advanced Surgical Devices at Smith & Nephew
1-2012 - 6-2014
Undergraduate Student Researcher at Stanford University School of Engineering

Education

2019 - 2021
Master of Business Administration - MBA from MIT Sloan School of Management
2010 - 2014
Bachelor's Degree from Stanford University

More Information

Social Presence :

Prographics :

Exp : 11 Location : New York, New York, United States Job Level : Leadership Designation : Co-founder and Managing Partner at Pineway Capital
URL has been copied!

Insights For Selling To Chris

During A Call Or A Meeting

DO's

  • Don’t forget to mention how you compare to competition on both features and pricing
  • If you can, show them industry reports or analyst comments instead of sharing anecdotal stories
  • Be formal and objective, they will appreciate it more

DONT's

  • Do not use very emotional or colorful language
  • Don't give superficial answers, they are easily rattled by them
  • Avoid pushing them too much to involve other stakeholders unless it is critical

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Chris is

  • Proof of ROI, low pricing and objective proof points are the important factors for them.
  • Will you ever get a clear answer from Chris

  • They do not mind saying no if they believe that it is the right decision.

Insights For Deal Planning

    How fast (or slow) will Chris move?

  • Their decision-making is neither very fast nor very slow, they are somewhere in between.
  • Can Chris take some risk or not?

  • They can take risks if their analysis shows that it would be worth it.

You And Chris

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.